According to the Zhitong Finance App, Haiwang Interlon (08329) announced that on November 11, 2026, Shenzhen Haiwang Biotechnology Co., Ltd. (Haiwang Biotech), the controlling shareholder of the company, has signed six share pledge agreements with an independent third party, Jilin Jiutai Rural Commercial Bank Co., Ltd. Changchun Branch (Jiutai Commercial Bank). According to these agreements, Haiwang Biotech agreed to pledge 1,181 million common shares in the issued share capital of the company with Jiutai Commercial Bank as collateral (share pledge) for two separate loans (such loans). One loan was provided by Jiutai Commercial Bank to Jilin Haiwang Yinhe Pharmaceutical Investment Co., Ltd., and the other loan was provided by Jiutai Commercial Bank to Changchun Kunlan Agricultural Technology Co., Ltd. Both companies are wholly-owned subsidiaries of Haiwang Biotech. The total principal amount of these loans was RMB 1,039 million. The relevant share pledge was registered on November 12, 2026 and will take effect from the date of registration.

At the date of this announcement, the total number of pledged shares accounted for about 70.38% of the issued share capital of the Company.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.